At BioSTL, we remain committed to making St. Louis a global hub for neuroscience innovation, even after learning our NEURO360 initiative was not selected for a $160 million NSF Engines grant. Together with WashU and regional partners, we are moving forward with the strategic plan developed through an earlier NSF award, focusing on translating research into new treatments, recruiting talent, and building a robust neuroscience ecosystem. Already, our efforts have accelerated company recruitment and brought neuroscience to the forefront of our Global Health Innovation Summit. This long-term vision will take decades, but with sustained investment and community support, St. Louis is poised to lead in advancing neuroscience and improving human health worldwide.
Read More at